POPTISELECT
LIVE

Serial Number

79257091

Owner

CEVEC Pharmaceuticals GmbH

Attorney

Dyan M. House

Filing Date

Jan 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

POPTISELECT Trademark

Serial Number: 79257091 • Registration: 6010253

POPTISELECT is a trademark filed by CEVEC Pharmaceuticals GmbH on January 9, 2019. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CEVEC Pharmaceuticals GmbH (7 trademarks)

Gottfried-Hagen-Strasse 62
51105 Köln , DE

Entity Type: 03

Trademark Details

Filing Date

January 9, 2019

Registration Date

March 17, 2020

Published for Opposition

December 31, 2019

Goods & Services

Chemical, biological and biochemical substances, preparations and reagents for scientific research, laboratory research, industrial and commercial purposes, except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical substances, preparations and reagents for researching and characterizing diseases except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical substances, preparations and reagents for scientific and medical research and drug development except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical substances, preparations and reagents for manufacturing drugs and pharmaceuticals, except chromatography chemicals and media, and except chemicals for use in separation and purification; cultures of microorganisms, proteins, polypeptides, nucleotides, nucleic acids, in particular plasmids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells for scientific research, laboratory research, industrial and commercial purposes; all of the foregoing other than for medical or veterinary purposes

Scientific and industrial research, in particular in the fields of medicine, pharmacy, molecular biology, biotechnology and genetics; research and development of drugs, diagnostic and analytical preparations, therapy procedures and expression systems; scientific and technological research and development services and related consultancy, in particular in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific research and development relating to the cultivation, extraction, optimization, synthesizing and modifying of eukaryotic cell lines, eukaryotic cells, microorganisms, polypeptides, proteins, nucleotides, nucleic acids, for third parties, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific research, analysis and development services relating to the breeding, obtaining, optimizing, synthesizing and modifying eukaryotic cell lines, eukaryotic cells, in particular transfected and selected eukaryotic cells and eukaryotic cell lines with a nucleic acid, in particular a plasmid, for third parties, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; scientific analysis and development of transfected eukaryotic cells and eukaryotic cell lines for third parties, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics; all afore mentioned services except services relating to capture and intermediate purification of proteins

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 17, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2024 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 9, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 9, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 9, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 9, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 9, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 9, 2024 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 19, 2023 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 21, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 21, 2023 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Aug 21, 2023 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 21, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 21, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 21, 2023 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 13, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 13, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 13, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 13, 2021 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 11, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 11, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 11, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 11, 2021 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 14, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 27, 2020 FICS
FINAL DISPOSITION PROCESSED
Jul 27, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 17, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 17, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Jan 4, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2019 NONP
ASSIGNED TO LIE
Nov 20, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 13, 2019 TROA
REFUSAL PROCESSED BY IB
Jun 14, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 25, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 25, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 30, 2019 RFCR
APPLICATION FILING RECEIPT MAILED
Apr 30, 2019 MAFR
NON-FINAL ACTION WRITTEN
Apr 29, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 26, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 25, 2019 REPR